Acadia Healthcare Issues Statement with Respect to Government Investigation
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/26/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
Acadia Healthcare (ACHC) PT Lowered to $76 at Barclays Amid Double Digit Percentage Selloff
September 27, 2024 2:29 PM EDTBarclays analyst Andrew Mok lowered the price target on Acadia Healthcare (NASDAQ: ACHC) to $76.00 (from $83.00) while maintaining a Overweight rating.
The analyst comments "Our Thoughts: The developments are clearly negative and prolong an unfavorable cycle of legal, regulatory, and media attention... More
